Abstract

Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and lung infections have critical consequences on mortality and morbidity in humans. The aims of the present study were to examine the mechanisms by which CXCL12 affects MUC1 transcription and airway inflammation, which depend on activator of G-protein signaling (AGS) 3 and to identify specific molecules that suppress CXCL12-induced airway inflammation by acting on G-protein-coupled receptors. Herein, AGS3 suppresses CXCL12-mediated upregulation of MUC1 and TNFα by regulating Gαi. We found that the G-protein regulatory (GPR) motif peptide in AGS3 binds to Gαi and downregulates MUC1 expression; in contrast, this motif upregulates TNFα expression. Mutated GPR Q34A peptide increased the expression of MUC1 and TGFβ but decreased the expression of TNFα and IL-6. Moreover, CXCR4-induced dendritic extensions in 2D and 3D matrix cultures were inhibited by the GPR Q34A peptide compared with a wild-type GPR peptide. The GPR Q34A peptide also inhibited CXCL12-induced morphological changes and inflammatory cell infiltration in the mouse lung, and production of inflammatory cytokines in bronchoalveolar lavage (BAL) fluid and the lungs. Our data indicate that the GPR motif of AGS3 is critical for regulating MUC1/Muc1 expression and cytokine production in the inflammatory microenvironment.

Highlights

  • Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and lung infections have critical consequences on mortality and morbidity in humans

  • We found that the G-protein regulatory (GPR) motif peptide in AGS3 binds to Gαi and downregulates MUC1 expression; in contrast, this motif upregulates TNFα expression

  • Our results suggest that CXCL12 induces MUC1 expression via CXCR4/Gαi signaling in airway epithelial cells

Read more

Summary

Introduction

Respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and lung infections have critical consequences on mortality and morbidity in humans. The GPR Q34A peptide inhibited CXCL12-induced morphological changes and inflammatory cell infiltration in the mouse lung, and production of inflammatory cytokines in bronchoalveolar lavage (BAL) fluid and the lungs. Our data indicate that the GPR motif of AGS3 is critical for regulating MUC1/Muc[1] expression and cytokine production in the inflammatory microenvironment. Understanding the characteristics of mucins that control the production of inflammatory cytokines and subsequent down-regulation of airway inflammation in respiratory diseases is essential for developing novel therapeutic compounds against inflammation. Under disease circumstances, uncontrolled mucin hyperproduction and hypersecretion can modulate cytokine production to increase or decrease airway inflammation. Elucidating of the intracellular mechanisms underlying the negative regulation of cytokine-induced mucin overproduction should reveal important clues toward understanding airway mucous hypersecretion[2,3]. CXCR7), cells were treated with CXCL12 for 24 hours prior to the collection of total RNA for conventional RTPCR (for CXCR4 transcript) and real-time quantitative RT-PCR. *p < 0.05 compared to the control, **p < 0.05 compared to CXCL12 treatment only, and ***p < 0.05 compared to CXCR4 transfection. β2​M, Beta-2-

Objectives
Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.